Does the Addition of Mutations of CTNNB1 S45F to Clinical Factors Allow Prediction of Local Recurrence in Patients With a Desmoid Tumor? A Local Recurrence Risk Model.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical orthopaedics and related research"
DOI: 10.1097/corr.0000000000002627
Abstract: BACKGROUND The initial approach to the treatment of desmoid tumors has changed from surgical resection to watchful waiting. However, surgery is still sometimes considered for some patients, and it is likely that a few patients… read more here.
Keywords: patients desmoid; local recurrence; risk; recurrence ... See more keywords
MRI characteristics predict the efficacy of meloxicam treatment in patients with desmoid‐type fibromatosis
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Medical Imaging and Radiation Oncology"
DOI: 10.1111/1754-9485.12940
Abstract: This study aimed to determine the clinical significance of MRI characteristics as a possible predictor of responsiveness to meloxicam treatment in patients with desmoid‐type fibromatosis (DF). Additionally, it analysed the correlation between CTNNB1 mutation status… read more here.
Keywords: meloxicam treatment; type fibromatosis; mri characteristics; patients desmoid ... See more keywords